Home › Trial NCT02120807
Certolizumab in Combination With Chemotherapy for Patients With Stage IV Lung Adenocarcinomas
- Trial IDNCT02120807
- StatusCompleted
- PhasePhase 1
- Study typeInterventional
- SponsorMemorial Sloan Kettering Cancer Center
- Enrollment30
- Start date2014-04-15
- ConditionsStage IV Lung Adenocarcinoma
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.